BRAF and non-small cell lung carcinoma: In Western nations, approximately 53% of NSCLC cases exhibit mutations in three genes: the Kirsten rat sarcoma virus (KRAS), epidermal growth factor receptor (EGFR), or B-Raf Proto-Oncogene, Serine/Threonine Kinase (BRAF).